These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 19389456)
21. No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophrenia. Deng C; Han M; Huang XF Neurosci Bull; 2007 Nov; 23(6):341-7. PubMed ID: 18064064 [TBL] [Abstract][Full Text] [Related]
22. Genetic variation in the 5-HT2A receptor and altered neocortical [3H] ketanserin binding in Alzheimer's disease. Holmes C; McCulley M; Nicoll JA; Alder JT; Chen CP; Francis PT Neurosci Lett; 2007 Jun; 420(1):58-60. PubMed ID: 17481814 [TBL] [Abstract][Full Text] [Related]
24. Contribution of the peripheral 5-HT 2A receptor to mechanical hyperalgesia in a rat model of neuropathic pain. Nitanda A; Yasunami N; Tokumo K; Fujii H; Hirai T; Nishio H Neurochem Int; 2005 Nov; 47(6):394-400. PubMed ID: 16051396 [TBL] [Abstract][Full Text] [Related]
25. Differential expression of 5-HT(2A) and 5-HT(2C) receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity. Huang XF; Han M; Storlien LH Brain Res Mol Brain Res; 2004 Aug; 127(1-2):39-47. PubMed ID: 15306119 [TBL] [Abstract][Full Text] [Related]
26. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Broderick PA; Olabisi OA; Rahni DN; Zhou Y Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963 [TBL] [Abstract][Full Text] [Related]
27. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease. Lai MK; Tsang SW; Alder JT; Keene J; Hope T; Esiri MM; Francis PT; Chen CP Psychopharmacology (Berl); 2005 May; 179(3):673-7. PubMed ID: 15551121 [TBL] [Abstract][Full Text] [Related]
28. Hippocampal 5-hydroxytryptamine receptors: abnormalities in postmortem brain from schizophrenic subjects. Scarr E; Pavey G; Copolov D; Dean B Schizophr Res; 2004 Dec; 71(2-3):383-92. PubMed ID: 15474910 [TBL] [Abstract][Full Text] [Related]
29. Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia. Pralong D; Tomaskovic-Crook E; Opeskin K; Copolov D; Dean B Schizophr Res; 2000 Jul; 44(1):35-45. PubMed ID: 10867310 [TBL] [Abstract][Full Text] [Related]
30. Serotonin 2A receptors and visual hallucinations in Parkinson disease. Ballanger B; Strafella AP; van Eimeren T; Zurowski M; Rusjan PM; Houle S; Fox SH Arch Neurol; 2010 Apr; 67(4):416-21. PubMed ID: 20385906 [TBL] [Abstract][Full Text] [Related]
31. A voxel-by-voxel analysis of [18F]setoperone PET data shows no substantial serotonin 5-HT(2A) receptor changes in schizophrenia. Verhoeff NP; Meyer JH; Kecojevic A; Hussey D; Lewis R; Tauscher J; Zipursky RB; Kapur S Psychiatry Res; 2000 Oct; 99(3):123-35. PubMed ID: 11068194 [TBL] [Abstract][Full Text] [Related]
32. Disrupted pattern of D2 dopamine receptors in the temporal lobe in schizophrenia. A postmortem study. Goldsmith SK; Shapiro RM; Joyce JN Arch Gen Psychiatry; 1997 Jul; 54(7):649-58. PubMed ID: 9236549 [TBL] [Abstract][Full Text] [Related]
33. Platelet 5-HT(2A) receptors in schizophrenic patients with and without neuroleptic treatment. Govitrapong P; Chagkutip J; Turakitwanakan W; Srikiatkhachorn A Psychiatry Res; 2000 Sep; 96(1):41-50. PubMed ID: 10980325 [TBL] [Abstract][Full Text] [Related]
34. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia. Hurlemann R; Boy C; Meyer PT; Scherk H; Wagner M; Herzog H; Coenen HH; Vogeley K; Falkai P; Zilles K; Maier W; Bauer A Anat Embryol (Berl); 2005 Dec; 210(5-6):519-23. PubMed ID: 16187138 [TBL] [Abstract][Full Text] [Related]
35. Evidence for altered post-receptor modulation of the serotonin 2a receptor in schizophrenia. Dean B; Crossland N; Boer S; Scarr E Schizophr Res; 2008 Sep; 104(1-3):185-97. PubMed ID: 18693083 [TBL] [Abstract][Full Text] [Related]
36. Superior temporal gyrus in schizophrenia: a volumetric magnetic resonance imaging study. Rajarethinam RP; DeQuardo JR; Nalepa R; Tandon R Schizophr Res; 2000 Jan; 41(2):303-12. PubMed ID: 10708339 [TBL] [Abstract][Full Text] [Related]